Towards Healthcare
Cell and Gene Therapy Thawing Equipment Market Drives at 14.24% CAGR by 2034

Cell and Gene Therapy Thawing Equipment Market Demand Rising

Market insights predict the global cell and gene therapy thawing equipment industry will increase from USD 0.96 billion in 2024 to USD 3.56 billion by 2034, achieving a CAGR of 14.24%. The Cold-chain expansion for CGT is estimated to drive the growth of the market in the near future. North America led the global market owing to the presence of advanced biopharma and CDMO hubs in the region.

Content

  • Insight Code: 6116
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

Talk to us
FAQ's

The cell and gene therapy thawing equipment market holds a valuation of USD 1.1 billion as of 2025, and will expand to USD 3.56 billion by 2034, achieving a CAGR of 14.24% between 2024 and 2034.

North America is leading the cell and gene therapy thawing equipment market due to the growing prevalence of chronic disease, increasing funding and investments, and the presence of key players.

The Cell and Gene Therapy Thawing Equipment market includes five segments including by product type, by workflow stage, by therapy type, by end-user, and by region.

Key trends include the growing need for biologics, investment and funding, government initiatives, and adoption of inorganic growth strategies.

ASGCT - American Society of Gene & Cell Therapy, Personalized Medicine Coalition, Alliance for Regenerative Medicine, Government of Canada, American Society of Gene and Cell Therapy, Food and Drug Administration, Alliance for Cancer Gene Therapy, clinicaltrials.gov, GOV.UK
Any Questions